Tag: clinically

Alnylam to Advance Zilebesiran into Global Phase 3 Cardiovascular Outcomes Trial

- Phase 3 Trial Informed by KARDIA-3 Phase 2 Study Results Presented…

Business Wire

Angelalign Technology Denies Patent Infringement and Vows Vigorous Defense

SAN CLEMENTE, Calif., Aug. 20, 2025 /PRNewswire/ -- Angelalign Technology Inc. (6699.HK) ("Angel") categorically denies…

PRNW Agency

Rhythm Pharmaceuticals Presents Data on MC4R Agonists Setmelanotide and Bivamelagon at ENDO 2025

- Presentations highlight clinically meaningful reductions in BMI in patients with acquired…

GlobeNews Wire

EyeCare Partners Releases Inaugural Quality and Outcomes Report, Showcasing Impact and Industry-Leading Benchmarks

ST. LOUIS--(BUSINESS WIRE)--EyeCare Partners (ECP), the nation’s leading provider of clinically integrated…

Business Wire